標(biāo)題: Titlebook: Immunoconjugate Therapy of Hematologic Malignancies; Steven T. Rosen,Timothy M. Kuzel Book 1993 Springer Science+Business Media New York 1 [打印本頁] 作者: 五個(gè) 時(shí)間: 2025-3-21 19:34
書目名稱Immunoconjugate Therapy of Hematologic Malignancies影響因子(影響力)
書目名稱Immunoconjugate Therapy of Hematologic Malignancies影響因子(影響力)學(xué)科排名
書目名稱Immunoconjugate Therapy of Hematologic Malignancies網(wǎng)絡(luò)公開度
書目名稱Immunoconjugate Therapy of Hematologic Malignancies網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Immunoconjugate Therapy of Hematologic Malignancies被引頻次
書目名稱Immunoconjugate Therapy of Hematologic Malignancies被引頻次學(xué)科排名
書目名稱Immunoconjugate Therapy of Hematologic Malignancies年度引用
書目名稱Immunoconjugate Therapy of Hematologic Malignancies年度引用學(xué)科排名
書目名稱Immunoconjugate Therapy of Hematologic Malignancies讀者反饋
書目名稱Immunoconjugate Therapy of Hematologic Malignancies讀者反饋學(xué)科排名
作者: IRS 時(shí)間: 2025-3-21 22:46 作者: CURL 時(shí)間: 2025-3-22 04:07
Treatment of leukemia with radiolabeled monoclonal antibodies,rate that has been achieved by combining chemotherapy with external beam whole-body irradiation and bone marrow transplantation in a small number of eligible patients is based on eradicating virtually all normal and neoplastic hematopoietic cells. Such an approach implicitly acknowledges that select作者: 好忠告人 時(shí)間: 2025-3-22 07:17 作者: 淘氣 時(shí)間: 2025-3-22 11:11
New approaches to radiolabeling monoclonal antibodies,sults have been obtained in both radioimmunoimaging and radioimmunotherapy trials, several problems related to the biodistribution of radiolabeled monoclonal antibodies have been observed, including the relatively low accumulation of activity in tumor and the excessive accumulation of activity in no作者: 脆弱么 時(shí)間: 2025-3-22 14:22 作者: Hyperalgesia 時(shí)間: 2025-3-22 20:18
Immunotoxins for the therapy of graft versus host disease,es, immunologic disorders, and genetic disorders. Acute graft versus host disease (GVHD), a potential major complication of allogeneic bone marrow transplants, remains a limitation to this approach. In the setting where an HLA-matched sibling is the marrow donor, 30–50% of patients undergoing marrow作者: Insufficient 時(shí)間: 2025-3-23 00:07
,Recombinant fusion toxins — A new class of targeted biologic therapeutics, of a toxin, typically diphtheria toxin or Pseudomonas exotoxin [.,.]. These single-chain polypeptides are built upon a product template contained within each toxin molecule. The toxin molecule has three functional domains: (1) the receptor binding domain or targeting ligand recognizes and attaches 作者: 反復(fù)拉緊 時(shí)間: 2025-3-23 02:42
Chimeric antibodies for the treatment of hematologic malignancy, the major goals of oncology is to refocus this capacity to mediate tumor specific destruction; to recreate, in effect, the inflammatory response that the tumor has avoided. Such a strategy demands the ability to activate and expand adequate quantities of effector cells (and proteins), to recruit th作者: cutlery 時(shí)間: 2025-3-23 06:31
Use of bispecific antibodies in the therapy of tumors,immune disease, graft rejection, and cancer. Although these immunoconjugates have considerable potential, problems associated with their toxicity have slowed their clinical application. Unconjugated MoAb, although not associated with as severe side effects, have generally had little biological activ作者: invert 時(shí)間: 2025-3-23 10:57
l conditioning procedures. Classical conditioning surely enjoys an extensive history within experimental psychology, with precursor associationistic formulations apparent throughout the history of philosophy and metaphysics (e.g., Descartes, Locke, Hobbes, J. S. Mill, etc.; excellent reviews by Jone作者: 懦夫 時(shí)間: 2025-3-23 17:23 作者: JIBE 時(shí)間: 2025-3-23 18:01 作者: 烤架 時(shí)間: 2025-3-23 22:17
George Sgouros,David A. Scheinberg analysis, both experimental and applied, has been dominated by a range of studies dedi- cated to providing ever more systematic and refined accounts of these "mainsprings of behavior control. " For the most part, the analysis has been pursued in the best traditions of "scientific methodology" with 作者: essential-fats 時(shí)間: 2025-3-24 02:41
Jorge Carrasquilloe perception of the Renaissance as an enlightening movement.This book explores the relationships between ancient witchcraft and its modern incarnation, and by doing so fills an important gap in the historiography. It is often noted that stories of witchcraft circulated in Greek and Latin classical t作者: 楓樹 時(shí)間: 2025-3-24 08:08 作者: N防腐劑 時(shí)間: 2025-3-24 14:39 作者: Bombast 時(shí)間: 2025-3-24 15:07
Thasia G. Woodworth,Jean C. Nicholseory anddiophantine approximation over recent years, one might fearthat the present work, originally published in Russian in1982, is mostly superseded. That is not so. A certain amountofupdating had been prepared by the author himself beforehis untimely death. Some further revision was prepared bycl作者: 廣口瓶 時(shí)間: 2025-3-24 21:23
mentum. The objects described by these laws have only mass and position. The properties of extended objects must be included in the theory by a process of summation or integration. In physics generally there are two situations of special interest: where the bodies are few in number, say up to 4 or 5作者: spinal-stenosis 時(shí)間: 2025-3-25 02:33 作者: Abrade 時(shí)間: 2025-3-25 07:04 作者: Aqueous-Humor 時(shí)間: 2025-3-25 08:26 作者: Lasting 時(shí)間: 2025-3-25 12:02
Treatment of leukemia with radiolabeled monoclonal antibodies,ting of clonogenic cells is abandoned, the effectiveness of nonspecific cell eradication remains inadequate. Improvements are clearly needed both in terms of targeting clonogenic cells and in the potency (relative to a given rate of normal tissue morbidity) of the cytotoxic agent. Radioimmunotherapy作者: NAUT 時(shí)間: 2025-3-25 17:01 作者: 神秘 時(shí)間: 2025-3-25 20:28
Use of bispecific antibodies in the therapy of tumors,sslinked, leading to the directed release of cytotoxic molecules from the effector cell. Many potentially useful MoAb are not of the appropriate isotype, and therefore are unable to activate human complement and/or trigger FcyR on human cells.作者: 繁榮地區(qū) 時(shí)間: 2025-3-26 00:20 作者: Infant 時(shí)間: 2025-3-26 07:07
lexes (conditioned stimulus-conditioned response; unconditioned stimulus-unconditioned response). The conditioned or acquired reflexes were optimistically offered as factual alternatives to “the fantastic speculations as to the existence of any possible subjective state in the animal which may be co作者: 使人入神 時(shí)間: 2025-3-26 09:56 作者: GULF 時(shí)間: 2025-3-26 12:51 作者: Favorable 時(shí)間: 2025-3-26 19:17
George Sgouros,David A. Scheinbergeen scratched. The primary focus of this pioneering effort extends the competing response analysis across all experimental schedules, both classical and instrumental, as well as the interactions between the two. Appropriately, the analysis empha- sizes overt behavioral interactions, beginning with the simples978-1-4612-6312-8978-1-4612-6310-4作者: Unsaturated-Fat 時(shí)間: 2025-3-26 23:14 作者: Lipoprotein 時(shí)間: 2025-3-27 03:40 作者: 顯微鏡 時(shí)間: 2025-3-27 05:46
n hydrodynamics will require four assumptions in addition to the assumption that a small element of the fluid obeys Newton’s second law. Except for Sects. 4.5 and 4.6 this chapter will be concerned with the simplest cases, in which the . particles can be considered one at a time, each one obeying Ne作者: 過分自信 時(shí)間: 2025-3-27 09:49 作者: 畏縮 時(shí)間: 2025-3-27 17:41
New approaches to radiolabeling monoclonal antibodies,njected dose per gram, localizes in tumor following intravenous injection [.]. The low tumor uptake in patients may be related to such factors as antibody dilution following injection [.], the slow rate of diffusion or penetration of antibody molecules across the vascular endothelium [.], and restricted blood flow in tumor tissue [.].作者: Ethics 時(shí)間: 2025-3-27 21:06
Immunotoxins for the therapy of graft versus host disease,ransplant therapy to those without such a donor through the use of bone marrow from mismatched related or matched unrelated donors. Once moderate to severe GVHD occurs, up to half of patients will die despite therapeutic intervention.作者: nephritis 時(shí)間: 2025-3-27 22:22
Radioimmunotherapy of lymphoma,, mention new obstacles to successful incorporation of radiolabeled MoAbs into standard oncologic therapy, and suggest future directions that may lead to enhanced effectiveness of radioimmunoconjugates.作者: CUMB 時(shí)間: 2025-3-28 04:14
Imaging and dosimetry determinations using radiolabeled antibodies, technology [.], the development of radiolabeled anti-tumor monoclonal antibodies (MoAb) as imaging and therapeutic reagents promises to add an element of specificity not previously available with conventional techniques.作者: 惡名聲 時(shí)間: 2025-3-28 08:15 作者: 單挑 時(shí)間: 2025-3-28 12:30 作者: Bricklayer 時(shí)間: 2025-3-28 15:23
978-1-4613-6343-9Springer Science+Business Media New York 1993作者: exceed 時(shí)間: 2025-3-28 21:09
Immunoconjugate Therapy of Hematologic Malignancies978-1-4615-3076-3Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: 發(fā)炎 時(shí)間: 2025-3-28 23:43 作者: 范圍廣 時(shí)間: 2025-3-29 05:42
https://doi.org/10.1007/978-1-4615-3076-3antigen; cancer treatment; immunotherapy; leukemia; lymphoma; targeted therapy; tumor作者: Acupressure 時(shí)間: 2025-3-29 08:07
